CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 160 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,593,000 | -62.9% | 198,983 | -64.4% | 0.62% | -59.2% |
Q2 2022 | $15,061,000 | -29.6% | 558,636 | -11.1% | 1.51% | +2.6% |
Q1 2022 | $21,402,000 | +14.3% | 628,356 | +29.7% | 1.47% | +30.6% |
Q4 2021 | $18,719,000 | -28.4% | 484,453 | 0.0% | 1.13% | -3.8% |
Q3 2021 | $26,156,000 | -19.3% | 484,453 | -50.0% | 1.17% | -16.3% |
Q2 2021 | $32,400,000 | +21.7% | 968,906 | -25.0% | 1.40% | +50.1% |
Q1 2021 | $26,613,000 | +17.6% | 1,291,875 | 0.0% | 0.94% | -7.4% |
Q4 2020 | $22,634,000 | -11.4% | 1,291,875 | -25.0% | 1.01% | -31.6% |
Q3 2020 | $25,545,000 | +22.8% | 1,722,500 | +7.7% | 1.48% | -1.0% |
Q2 2020 | $20,800,000 | – | 1,600,000 | – | 1.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |